press

Antibody detection in body fluids can inform clinicians about a person’s encounter with various pathogens as well as the diagnosis of autoimmune or other diseases. However, despite their widespread implementation, serological assays suffer from a lack of sensitivity and specificity, necessitating the continuous research for alternative approaches. Funded by the Marie Skłodowska-Curie Actions programme, the overarching goal of the Nano-ImmunoEra project is to develop nanotechnology-based biosensors and diagnostic tools for the detection of clinically relevant antibodies. The project primarily involves activities for the training of the next generation of scientists in the field of materials sciences, nanotechnology, molecular biology and biosensors.